Abstract:Individualized treatment rules can improve health outcomes by recognizing that patients may respond differently to treatment and assigning therapy with the most desirable predicted outcome for each individual. Flexible and efficient prediction models are desired as a basis for such individualized treatment rules to handle potentially complex interactions between patient factors and treatment. Modern Bayesian semiparametric and nonparametric regression models provide an attractive avenue in this regard as these allow natural posterior uncertainty quantification of patient specific treatment decisions as well as the population wide value of the prediction-based individualized treatment rule. In addition, via the use of such models, inference is also available for the value of the optimal individualized treatment rules. We propose such an approach and implement it using Bayesian Additive Regression Trees as this model has been shown to perform well in fitting nonparametric regression functions to continuous and binary responses, even with many covariates. It is also computationally efficient for use in practice. With Bayesian Additive Regression Trees, we investigate a treatment strategy which utilizes individualized predictions of patient outcomes from Bayesian Additive Regression Trees models. Posterior distributions of patient outcomes under each treatment are used to assign the treatment that maximizes the expected posterior utility. We also describe how to approximate such a treatment policy with a clinically interpretable individualized treatment rule, and quantify its expected outcome. The proposed method performs very well in extensive simulation studies in comparison with several existing methods. We illustrate the usage of the proposed method to identify an individualized choice of conditioning regimen for patients undergoing hematopoietic cell transplantation and quantify the value of this method of choice in relation to the optimal individualized treatment rule as well as non-individualized treatment strategies.

A Bayesian multivariate hierarchical model for developing a treatment benefit index using mixed types of outcomes

Bayesian Index Models for Heterogeneous Treatment Effects on a Binary Outcome

Optimal Bayesian Hierarchical Model to Accelerate the Development of Tissue-Agnostic Drugs and Basket Trials.

A Bayesian Platform Trial Design to Simultaneously Evaluate Multiple Drugs in Multiple Indications with Mixed Endpoints.

A Single Index Model for Longitudinal Outcomes to Optimize Individual Treatment Decision Rules

Bayesian Nonparametric Model for Heterogeneous Treatment Effects With Zero‐Inflated Data

Bayesian Group Sequential Enrichment Designs Based on Adaptive Regression of Response and Survival Time on Baseline Biomarkers.

A Bayesian Phase II Proof-of-concept Design for Clinical Trials with Longitudinal Endpoints.

Decision making and uncertainty quantification for individualized treatments using Bayesian Additive Regression Trees

A Bayesian joint model of multiple longitudinal and categorical outcomes with application to multiple myeloma using permutation-based variable importance

Optimal Statistical Inference for Individualized Treatment Effects in High-dimensional Models

Decision making and uncertainty quantification for individualized treatments

Bayesian Inference of Individualized Treatment Effects using Multi-task Gaussian Processes

A Bayesian Basket Trial Design Using a Calibrated Bayesian Hierarchical Model

Selection of the Optimal Personalized Treatment from Multiple Treatments with Right-censored Multivariate Outcome Measures

A nonparametric framework for treatment effect modifier discovery in high dimensions

High-dimensional model-assisted inference for treatment effects with multi-valued treatments

Patient stratification in multi-arm trials: a two-stage procedure with Bayesian profile regression

Bayesian Solutions for Assessing Differential Effects in Biomarker Positive and Negative Subgroups

How to relate potential outcomes: Estimating individual treatment effects under a given specified partial correlation

Identifying treatment effect heterogeneity in dose-finding trials using Bayesian hierarchical models